A new study led by scientists at the Stanford School of Medicine found that a drug called omalizumab can prevent dangerous allergic responses in children with food allergies, even to small amounts of allergy-triggering foods. The FDA recently approved omalizumab for reducing the risk of allergic reactions to foods. The study showed that after receiving the drug, two-thirds of participants could safely eat small amounts of their food triggers. Omalizumab, originally approved for other allergic conditions, may offer a new treatment option for multi-food allergic patients, providing relief from multiple food allergens simultaneously. More research is needed to understand the drug’s long-term effects and patient responses.
Source link
Drug limits dangerous reactions to allergy-triggering foods, pediatric study finds
